Branched-chain amino acids are associated with cardiometabolic risk profiles found already in lean, overweight and obese young
- PMID: 27142745
- DOI: 10.1016/j.jnutbio.2016.02.007
Branched-chain amino acids are associated with cardiometabolic risk profiles found already in lean, overweight and obese young
Abstract
Cardiovascular risk is increased in obese subjects. Nevertheless, some overweight and obese remain cardiometabolically healthy (CMH), and normal-weight persons develop cardiovascular disease (CVD). Herein, we investigate the potential of branched-chain amino acids (BCAAs) to identify an increased CVD risk in a cross-sectional study of 666 adults and juveniles (age 25.3±12.8years), classified as lean, overweight or obese. Cardiometabolic groups were defined by cutoffs of systolic blood pressure<130mmHg, diastolic blood pressure<85mmHg, glucose<125mg/dl, triglycerides<150mg/dl, HDL-cholesterol>40mg/dl (males), HDL-cholesterol>50mg/dl (females) and HOMA-IR<5. CMH had ≤1 cutoff, and cardiometabolically abnormal (CMA) had ≥2 cutoffs. Amino acids were measured by high-pressure lipid chromatography after precipitation of serum with perchloric acid and derivatization with o-phthalaldehyde. Valine correlated with 5, leucine correlated with 3 and isoleucine correlated with 5 of the cardiac risk classification factors. Valine and leucine were significantly higher in the obese (P<.001, P=.015, respectively), overweight (P<.001, P=.015, respectively) and lean (P=.024, P=.012, respectively) CMA compared to CMH subjects. Isoleucine showed except of the lean group the same results. Taken together, BCAAs, especially valine and leucine, are proposed as a cardiometabolic risk marker independent of body mass index (BMI) category.
Keywords: Body mass index; Branched-chain amino acids; Cardiometabolic risk.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Branched chain amino acids are novel biomarkers for discrimination of metabolic wellness.Metabolism. 2013 Jul;62(7):961-9. doi: 10.1016/j.metabol.2013.01.007. Epub 2013 Feb 1. Metabolism. 2013. PMID: 23375209 Free PMC article. Clinical Trial.
-
Mother's pre-pregnancy BMI is an important determinant of adverse cardiometabolic risk in childhood.Pediatr Diabetes. 2015 Sep;16(6):419-26. doi: 10.1111/pedi.12273. Epub 2015 Mar 20. Pediatr Diabetes. 2015. PMID: 25800542 Free PMC article.
-
"Leaner and less fit" children have a better cardiometabolic profile than their "heavier and more fit" peers: the Healthy Growth Study.Nutr Metab Cardiovasc Dis. 2013 Nov;23(11):1058-65. doi: 10.1016/j.numecd.2012.11.010. Epub 2013 May 13. Nutr Metab Cardiovasc Dis. 2013. PMID: 23680122
-
An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases.Prog Cardiovasc Dis. 2018 Jul-Aug;61(2):142-150. doi: 10.1016/j.pcad.2018.07.003. Epub 2018 Jul 5. Prog Cardiovasc Dis. 2018. PMID: 29981771 Review.
-
Cardiometabolic risk variables in overweight and obese children: a worldwide comparison.Cardiovasc Diabetol. 2011 Nov 24;10:106. doi: 10.1186/1475-2840-10-106. Cardiovasc Diabetol. 2011. PMID: 22114790 Free PMC article. Review.
Cited by
-
PNPLA3 Genotype and Dietary Fat Modify Concentrations of Plasma and Fecal Short Chain Fatty Acids and Plasma Branched-Chain Amino Acids.Nutrients. 2024 Jan 16;16(2):261. doi: 10.3390/nu16020261. Nutrients. 2024. PMID: 38257154 Free PMC article. Clinical Trial.
-
Recent Advances in Microbiota-Associated Metabolites in Heart Failure.Biomedicines. 2023 Aug 21;11(8):2313. doi: 10.3390/biomedicines11082313. Biomedicines. 2023. PMID: 37626809 Free PMC article. Review.
-
The Effect of Carbohydrate Restriction on Lipids, Lipoproteins, and Nuclear Magnetic Resonance-Based Metabolites: CALIBER, a Randomised Parallel Trial.Nutrients. 2023 Jun 30;15(13):3002. doi: 10.3390/nu15133002. Nutrients. 2023. PMID: 37447328 Free PMC article. Clinical Trial.
-
Alterations in gut microbiota and urine metabolomics in infants with yin-deficiency constitution aged 0-2 years.Heliyon. 2023 Mar 24;9(4):e14684. doi: 10.1016/j.heliyon.2023.e14684. eCollection 2023 Apr. Heliyon. 2023. PMID: 37064462 Free PMC article.
-
Metabolite-assisted models improve risk prediction of coronary heart disease in patients with diabetes.Front Pharmacol. 2023 Mar 24;14:1175021. doi: 10.3389/fphar.2023.1175021. eCollection 2023. Front Pharmacol. 2023. PMID: 37033607 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical